Neurosarcoidosis mimicking multiple sclerosis successfully treated with methotrexate and adalimumab

International Journal of Rheumatic Diseases

Volumn 17, Issue 2, 2014, Pages 214-216

  Metyas, Samy ^a   Tawadrous, Magdy ^b   Yeter, Karen C ^a   Arkfeld, Daniel G ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Rheumatology Research Associate   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE; METHOTREXATE; PREDNISONE;

ADULT; ALOPECIA; ANTIBIOTIC THERAPY; BONE BIOPSY; BONE MARROW EDEMA; BREAST AUGMENTATION; BRONCHOSCOPY; CASE REPORT; CEREBROSPINAL FLUID; CERVICAL SPINE; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DEMYELINATION; DISEASE DURATION; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FAMILY HISTORY; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; HYPOREFLEXIA; INFLAMMATORY CELL; LETTER; LIMB WEAKNESS; LOW BACK PAIN; LUMBAR PUNCTURE; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG LAVAGE; MACROPHAGE; MIDDLE AGED; MIGRAINE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; PRIORITY JOURNAL; SARCOIDOSIS; SEIZURE; SPINE SURGERY;

ANTIBODIES, MONOCLONAL, HUMANIZED; CENTRAL NERVOUS SYSTEM DISEASES; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; METHOTREXATE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; REMISSION INDUCTION; SARCOIDOSIS; TREATMENT OUTCOME;

EID: 84896729289     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12122     Document Type: Letter

References (10)

1. Aladesanmi OA (2004) Sarcoidosis: An update for the primary care physician. MedGenMed 6, 7.
2. Burns TM (2003) Neurosarcoidosis. Arch Neurol 60, 1166-8.
3. Joseph FG, Scolding NJ (2007) Sarcoidosis of the nervous system. Pract Neurol 7, 234-44.
4. Khoury J, Wellik KE, Demaerschalk BM et al. (2009) Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist 15, 108-11.
5. Terushkin V, Stern BJ, Judson MA et al. (2010) Neurosarcoidosis: presentations and management. Neurologist 16, 2-15.
6. Santos E, Shaunak S, Renowden S et al. (2010) Treatment of refractory neurosarcoidosis with Infliximab. J Neurol Neurosurg Psychiatry 81, 241-6.
7. Hunninghake GW, Costabel U, Ando M et al. (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 16, 149-73.
8. Toth C, Morrish W, Coutts S et al. (2007) Dramatic MRI improvement with refractory neurosarcoidosis treated with infliximab. Acta Neurol Scand 116, 259-62.
9. Wanat K, Rosenback M (2012) Case series demonstrating improvement in chronic cutaneous sarcoidosis following treatment with TNF inhibitors. Arch Dermatol 148, 1097-100.
10. Marnane M, Lynch T, Scott J et al. (2009) Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab. J Neurol 256, 139-40.